Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH dose adjustment to different IGF-I target levels in adults with severe growth hormone deficiency
NL-OMON39563Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Vrije University Medical Center. Started May 2013; status: active, not recruiting.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NL-OMON39563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39563.